You are here

  • Home
  • Archive
  • Volume 16, Issue 3
  • Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only

Authors

  1. Correspondence to Richard B Lipton
    1165 Morris Park Ave/Bronx, NY 10461, USA; Richard.lipton{at}einstein.yu.edu
View Full Text

Citation

Lipton RB
Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only
BMJ Evidence-Based Medicine 2011;16:77-78.

Publication history

  • First published January 19, 2011.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions